Back
Cassava Sciences Vs. Monopar Therapeutics Industry Stock Comparison
Sell
43
SAVA
Cassava Sciences
Last Price:
$1.90
Seasonality Move:
9.17%
Sell
46
MNPR
Monopar Therapeutics
Last Price:
$37.99
Seasonality Move:
-13.48%
Sell
43
Cassava Sciences (SAVA)
is a Sell
Is Cassava Sciences a Buy, Sell or Hold?
-
The current Cassava Sciences [SAVA] share price is $2.80. The Score for SAVA is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
SAVA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $37.60. The Score for MNPR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $2.80Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $37.60The current trend is moderately bullish and MNPR is experiencing slight selling pressure.
SAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 52.79 | Buy |
Chaikin Money Flow: | -789107 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.48 - 2.8) | Buy |
Bollinger Bands (100): | (-1.98 - 17.92) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.33 | Buy |
Relative Strength Index (14 RSI): | 53.16 | Buy |
Chaikin Money Flow: | -4864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.9 - 41.16) | Buy |
Bollinger Bands (100): | (18.89 - 38.95) | Buy |
SAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.76 | Buy |
20-day SMA: | 2.66 | Buy |
50-day SMA: | 2.58 | Buy |
200-day SMA: | 15.48 | Sell |
8-day EMA: | 2.77 | Buy |
20-day EMA: | 2.7 | Buy |
50-day EMA: | 3.7 | Sell |
200-day EMA: | 12.56 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.16 | Buy |
20-day SMA: | 33.55 | Buy |
50-day SMA: | 36.72 | Buy |
200-day SMA: | 16.35 | Buy |
8-day EMA: | 37.12 | Buy |
20-day EMA: | 35.96 | Buy |
50-day EMA: | 34.41 | Buy |
200-day EMA: | 21.02 | Buy |
Cassava Sciences Earnings Growth & SAVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and a decrease next year of $1.54 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Cassava Sciences Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |